Webinar on Pediatric Chemo-Induced Hearing Loss to Be Held September 13

This half-day event follows the Food and Drug Administration’s (FDA) model for externally-led Patient Focused Drug Development meetings and serves to inform the agency’s regulatory decision-making in pediatric oncology.